Market for SNP Genotyping and Analysis Estimated to Witness High Growth Owing to Rising Public and Private Investments in Precision Medicine & Increasing Number of Clinical Trials

The SNP Genotyping and Analysis Market is estimated to be valued at US$ 20.2 Billion or Bn in 2023 and is expected to exhibit a CAGR of 21.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.